BenYang

[BenYang @Ikbenwy]

@zhang_bj_ 就差最后三个

[BenYang @Ikbenwy]

@Han_Akamatsu can I have $GlXY? thanks in advance

[PK_Fund @PK_Fund]

$IBRX asked Claude why the media largely ignored ibrx pancreatic cancer results,when they were technically better than Revolution's results. Here's what Claude said.

"You're right that the media largely ignored ImmunityBio. A non-toxic, outpatient immunotherapy that doubled survival in third-to-sixth line patients — people who had already failed multiple rounds of chemotherapy — is a remarkable signal. Those are the hardest patients to help. The fact that it got almost no mainstream coverage while Revolution Medicines dominated headlines does reflect some genuine biases"

[InvestmentGuru @InvestmentGuru_]

The U.S. Drone Race Is Accelerating — And The Market Is Finally Paying Attention

Reports suggest the Trump administration is advancing financing talks with multiple drone companies as part of a major push to expand domestic drone manufacturing and reduce reliance on foreign supply chains.

The discussions may include both debt financing and direct equity investment — meaning the U.S. government could potentially take stakes in selected drone companies.

Names reportedly involved:
→ $UMAC
→ Performance Drone Works
→ Neros Technologies

The market reacted immediately:
📈 $UMAC +30% premarket
📈 $RCAT +15%
📈 $ONDS +8%

This move could mark the beginning of a much larger U.S. defense drone buildout cycle.

Key drone stocks now on watch:

Defense & Tactical Drone Leaders
→ $AVAV — Switchblade, Puma, AI/autonomy expansion after BlueHalo acquisition
→ $KTOS — Multi-domain autonomous systems across air, land, and sea
→ $NOC — Global Hawk and advanced unmanned combat aircraft exposure
→ $RCAT — Black Widow tactical drones + maritime autonomous systems

AI, Software & Components
→ $UMAC — “Drone-to-Cloud” infrastructure, simulation, GPU rendering
→ $PDYN — AI autonomy software for drone targeting/tracking
→ $SES — Lithium-metal batteries for drones and urban air mobility

Commercial, Security & Counter-Drone
→ $ONDS — Autonomous drone platforms + counter-drone systems
→ $DPRO — ISR, reconnaissance, industrial inspection drones
→ $PRZO — Drone safety + interception systems
→ $UAVS — Tactical mapping drones with Blue UAS certification

The bigger picture:
Modern warfare is shifting toward autonomous, lower-cost, AI-enabled systems. Drones are becoming as strategically important as cybersecurity, satellites, and AI infrastructure.

This may not be a short-term headline trade alone — it could become a multi-year defense and autonomy investment theme.

Watch the capital flows carefully.

[Justin Banks @RealJGBanks]

The U.S. government is literally telling you where money is going next:

DRONES.

IF you missed out on the other Trump picks like $INTC and $DELL this your chance.

Trump is pursuing funding deals to boost domestic drone production.

Pure-Play Drone / Autonomy Names
$AVAV - military drones
$KTOS - autonomous warfare systems
$RCAT - Teal defense drones
$ONDS - drone autonomy + networks
$DPRO - FPV drone systems
$UMAC - U.S. drone supply chain
$SWMR - drone swarm technology
$PDYN - AI drone software
$AVEX - defense drone contractor

Counter-Drone / Defense Tech
$DRSHF - anti-drone defense
$LHX - ISR + drone warfare systems

Major Defense Exposure
$NOC - military UAV programs
$LMT - autonomous defense systems
$TXT - unmanned aircraft systems
$GD - defense systems exposure
$BA - UAV + aerospace programs

[BenYang @Ikbenwy]

wow $RCAT $15 , why do I go to work

[BenYang @Ikbenwy]

patience with $IBRX, conviction pays back well

[Bullish @bullishbruk]

$IBRX Urgent Call: Register Now for FDA Hearing on June 4
Patients, survivors, caregivers — if you face bladder cancer, chemo/radiation-induced lymphopenia, or most solid tumors (lung, pancreatic, breast, etc.), speak up!
ANKTIVA, an IL-15 agonist, activates NK/T cells, reverses lymphopenia, and shows broad potential across most tumors for better immune response and outcomes.
The FDA’s CNPV program offers fast-track review for national priority drugs. Join the June 4, 2026 public hearing (rescheduled) to demand urgent expanded access.
Act Today:
• Register to speak/attend the hybrid hearing.
• Share your story of cancer progression, immune collapse, or need for ANKTIVA.
• Submit comments by June 29 via Federal Register.
Your voice can accelerate approval. Register now — lives depend on it. @LoriMills4CA42 @DrPatrick

[BenYang @Ikbenwy]

$RCAT $KTOS are very early

[BenYang @Ikbenwy]

$RCAT $15 next week

[BenYang @Ikbenwy]

useless ONDS drone can't fight, a drone loser

[BenYang @Ikbenwy]

$RCAT is winning over $ONDS

[Dr. Thomas Ichim @exosome]

G-CSF Mobilized NK cells to treat #leukemia....just add some #anktiva by $IBRX and you have a cool treatment for leukemia...too bad its too late for my mom

https://t.co/yvp2dqej0A

[GainzAlgo @gainzalgo]

$IBRX Most “NK cell therapies” fail because they don’t create memory T cells, meaning the immune system never truly remembers or eliminates the cancer long term.
That’s why Patrick Soon-Shiong keeps emphasizing the “triangle offense” approach, stimulating memory T cells may be the real key to durable cancer cures. The deeper I dig, the more I realize how far ahead PSS is thinking.

[bluefinsashimi @bluefinsashimi]

$IBRX Imagine fighting bladder cancer without losing your bladder or facing cancer roaring back.

#ANKTIVA is an immunotherapy that boosts your natural killer cells and T-cells for a strong, lasting defense - like training your immune system to remember and keep fighting.

Price advantage: New analysis shows up to $314K lower cost per complete responder vs J&J's TAR-200 (chemo-releasing device). Lower drug + admin costs + better response rates = big savings for patients & Medicare, plus fewer expensive surgeries.

Efficacy: Higher modeled complete response rates (49.6% vs 45.9% for TAR-200). Many patients see their cancer disappear.

Durability (the big edge): Responses last much longer—median over 45 months in key data, with 51% of responders still cancer-free at 45+ months. Over 80-84% avoid bladder removal at 3 years.

Why others struggle: J&J's TAR-200 uses chemo (gemcitabine) which can wear down your body. Keytruda (systemic immunotherapy) often over-activates or exhausts the immune system, leading to side effects and higher chance of cancer returning. ANKTIVA builds real immune memory without destroying your defenses.

This is bladder-sparing, chemo-free power with real patient impact. Momentum is building!

Links:
https://t.co/XhBUvLClgB (Cost analysis)

https://t.co/W26LxAR0fi (Durability data)

[Serenity @aleabitoreddit]

https://t.co/IJPmDDBHcq

[BenYang @Ikbenwy]

@bennybigbull why do you prefer $AVAV over $KTOS?

[Manchurius Hao — Greeks.live首席赌狗 @AntonLaVay]

我跟你们说，美股这玩意儿，就真的是特简单，你就找这最热门行业中的的股票中，远期期权OI疯狂增加，远期IV开始上扬，LEAPS被明显扫货的公司。

老登股什么玩意儿跟你说稳健的直接隐藏。

然后跟单就这么简单，美股讲究的就是一个跟单，倍儿地道。

一定要关注LEAPS，那些13F大佬建仓全是LEAPS，短期期权韭菜的噪音太大了。

我几乎可以肯定 $nok 当下正在被13F大佬疯狂建仓，因为如果我们看到一份13F，反推他们是什么时候建仓的也是看OI的，

记住，小成交量可以被刷成大成交量，但是大成交量不能被伪装成小成交量，难以隐藏自身，因为OI在增加，IV在上扬。

凡是接触，必留痕迹。

我应该是当时最早发现 $nok LEAPS在被疯狂建仓的。

[LT 視界 @ltshijie]

醫生剛剛即時「關閉」了帕金森氏症的震顫 —— 治療前後的對比簡直令人難以置信

這段影片正在全網瘋傳……因為畫面中發生的一切看起來簡直是不可能的事。

前一刻：身體還在無法控制地顫抖。
僅僅片刻之後：便徹底恢復了平靜。

無需開刀手術。無需植入裝置。

只是透過磁振造影（MR）引導下的聚焦超音波技術，精準作用於大腦深處的一個微小區域。

• 曾經無法保持靜止的雙手…瞬間變得穩如泰山
• 劇烈的震顫…當場完全消失
• 病人隨即進行肢體活動測試 —— 效果竟然立竿見影
• 醫生在磁振造影掃描儀內，全程即時目睹了這一奇蹟的發生

這不是一個漸進的過程。
而是瞬間完成的。

如今，人們都在追問同一個問題：

既然這項技術確實存在……為什麼感覺卻鮮少被提及呢？

📹：TikTok/tremor.care

[Value Investing Edge @StonkValue]

The U.S. government, hyperscalers, and $NVDA are literally telling you that the future will be dominated by stocks below -

Space
1. $RKLB
2. $FLY
3. $SATL
4. $PL
5. $ASTS

Critical Minerals
1. $USAR
2. $UUUU
3. $MP
4. $UAMY

Energy
1. $AMPX
2. $TE
3. $EOSE
4. $BE

Memory/Storage
1. $SNDK
2. $MU
3. $WDC
4. $MARM
5. $SIMO

Defense
1. $ONDS
2. $OSS
3. $PLTR

Optical sector
1. $AAOI
2. $AXTI
3. $LWLG
4. $LITE
5. $COHR

Quantum
1. $IONQ
2. $QBTS
3. $RGTI

AI Infrastructures
1. $NBIS
2. $IREN
3. $CIFR
4. $ALAB

Semiconductor
1. $AMBQ
2. $NVTS
2. $MRVL
3. $AMD
4. $ARM
5. $WOLF

Nuclear
1. $OKLO

Hardest part of investing is having patience. Once you master it and compounding will change our life!

[BenYang @Ikbenwy]

@FINRACROOKS @gainzalgo why is he an idiot?